Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol
2002; 39: 1890–1900.
Lechat, P, Mas, JL, Lascault, G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med
1988; 318: 1148–1152.
Di Tullio, MR, Sacco, RL, Sciacca, RR, Jin, Z, Homma, S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol
2007; 49: 797–802.
Wahl, A, Krumsdorf, U, Meier, B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol
2005; 45: 377–380.
Cottens, D, Van De Bruaene, A, Troost, E, Willems, R, Moons, P, Budts, W. Influence of percutaneous transcatheter closure of an atrial septal defect on the atrioventricular conduction. Acta Cardiol
2011; 66: 309–314.
Moake, L, Ndinjiakat, SK. Transcatheter device closure for atrial septal defect: safety, efficacy, complications, and costs. Crit Care Nurs Clin North Am
2011; 23: 339–348.
Tang, C, Zeng, Z, Li, J, Cao, WZ, Huang, P. Amplatzer transcatheter and surgical closure for ostium secundum atrial septal defect: a systematic review. Chin J Evid Based Med
2007; 7: 267–275.
Berger, F, Ewert, P, Bjornstad, PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder. Cardiol Young
1999; 9: 468–473.
Carminati, M, Chessa, M, Butera, G, et al. Transcatheter closure of atrial septal defect with the STARFlex device: early results and follow-up. J Interv Cardiol
2001; 14: 319–324.
Das, GS, Voss, G, Jarvis, G, Wyche, K, Gunther, R, Wilson, RF. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation
1993; 88: 1754–1764.
Rome, JJ, Keane, JF, Perry, SB, Spevak, PJ, Lock, JE. Double-umbrella closure of atrial defects. Initial clinical applications. Circulation
1990; 82: 751–758.
Sideris, EB, Sideris, SE, Thanopoulos, BD, Ehly, RL, Fowlkes, JP. Transvenous atrial septal defect occlusion by the buttoned device. Am J Cardiol
1990; 66: 1524–1526.
Sievert, H, Babic, UU, Hausdorf, G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol
1998; 82: 1405–1413.
Zahn, EM, Wilson, N, Cutright, W, Latson, LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation
2001; 104: 711–716.
Deeks, JJ, Dinnes, J, D'Amico, R, et al. Evaluating non-randomised intervention studies. Health Technol Assess
2003; 7: iii–x; 1-173.
Hammerstingl, C, Bauriedel, B, Stusser, C, et al. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study. Eur J Med Res
2011; 16: 13–19.
Luermans, JG, Post, MC, ten Berg, JM, Plokker, HW, Suttorp, MJ. Long-term outcome of percutaneous closure of secundum-type atrial septal defect in adults. EuroIntervention
2010; 6: 604–610.
von Bardeleben, RS, Richter, C, Otto, J, et al. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: difference in occlusion systems and influence of atrial septum aneurysm. Int J Cardiol
2009; 134: 33–41.
Staubach, S, Steinberg, DH, Zimmermann, W, et al. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv
2009; 74: 889–895.
Becker, M, Frings, D, Schröder, J, et al. Impact of occluder device type on success of percutaneous closure of atrial septal defect – a medium-term follow-up study. J Interv Cardiol
2009; 22: 503–510.
Taaffe, M, Fischer, E, Baranowski, A, et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol
2008; 101: 1353–1358.
Luermans, JG, Post, MC, Plokker, HW, Ten Berg, JM, Suttorp, MJ. Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke. Neth Heart J
2008; 16: 332–336.
Hildick-Smith, D, Behan, M, Haworth, P, Rana, B, Thomas, M. Patent foramen ovale closure without echocardiographic control: use of “standby” intracardiac ultrasound. JACC Cardiovasc Interv
2008; 1: 387–391.
Slavin, L, Tobis, JM, Rangarajan, K, Dao, C, Krivokapich, J, Liebeskind, DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol
2007; 99: 1316–1320.
Mareedu, RK, Shah, MS, Mesa, JE, McCauley, CS. Percutaneous closure of patent foramen ovale: a case series and literature review. Clin Med Res
2007; 5: 218–226.
Harms, V, Reisman, M, Fuller, CJ, et al. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol
2007; 99: 1312–1315.
Egred, M, Andron, M, Albouaini, K, Alahmar, A, Grainger, R, Morrison, WL. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up. J Interv Cardiol
2007; 20: 395–401.
Aslam, F, Iliadis, AE, Blankenship, JC. Percutaneous closure of patent foramen ovale: success and outcomes of a low-volume procedure at a rural medical center. J Invasive Cardiol
2007; 19: 20–24.
Post, MC, Suttorp, MJ, Jaarsma, W, Plokker, HW. Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single-center experience. Catheter Cardiovasc Interv
2006; 67: 438–443.
Alaeddini, J, Feghali, G, Jenkins, S, Ramee, S, White, C, Abi-Samra, F. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol
2006; 18: 365–368.
Post, MC, Van Deyk, K, Budts, W. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome. Acta Cardiol
2005; 60: 515–519.
Ilkhanoff, L, Naidu, SS, Rohatgi, S, Ross, MJ, Silvestry, FE, Herrmann, HC. Transcatheter device closure of interatrial septal defect in patients with hypoxia. J Interv Cardiol
2005; 18: 227–232.
Azarbal, B, Tobis, J, Suh, W, Chan, V, Dao, C, Gaster, R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol
2005; 45: 489–492.
Varma, C, Benson, LN, Warr, MR, et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheter Cardiovasc Interv
2004; 62: 519–525.
Krumsdorf, U, Ostermayer, S, Billinger, K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol
2004; 43: 302–309.
Butera, G, Carminati, M, Chessa, M, et al. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defect. Am Heart J
2004; 148: 507–510.
Braun, M, Gliech, V, Boscheri, A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J
2004; 25: 424–430.
Anzai, H, Child, J, Natterson, B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol
2004; 93: 426–431.
Butera, G, De Rosa, G, Chessa, M, et al. Transcatheter closure of atrial septal defect in young children: results and follow-up. J Am Coll Cardiol
2003; 42: 241–245.
Bialkowski, J, Kusa, J, Szkutnik, M, et al. Percutaneous catheter closure of atrial septal defect. Short-term and mid-term results. Rev Esp Cardiol
2003; 56: 383–388.
Chessa, M, Carminati, M, Butera, G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol
2002; 39: 1061–1065.
Veldtman, GR, Razack, V, Siu, S, et al. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol
2001; 37: 2108–2113.
Sievert, H, Horvath, K, Zadan, E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol
2001; 14: 261–266.
Krumsdorf, U, Keppeler, P, Horvath, K, Zadan, E, Schrader, R, Sievert, H. Catheter closure of atrial septal defect and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol
2001; 14: 49–55.
Butera, G, Bini, MR, Chessa, M, Bedogni, F, Onofri, M, Carminati, M. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J
2001; 2: 115–118.
Acar, P, Saliba, Z, Bonhoeffer, P, Sidi, D, Kachaner, J. Assessment of the geometric profile of the Amplatzer and Cardioseal septal occluders by three dimensional echocardiography. Heart
2001; 85: 451–453.
Webster, MW, Chancellor, AM, Smith, HJ, et al. Patent foramen ovale in young stroke patients. Lancet
1988; 2: 11–12.
Mas, JL, Arquizan, C, Lamy, C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med
2001; 345: 1740–1746.
Paciaroni, M, Agnelli, G, Bertolini, A, et al. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis
2011; 31: 109–116.
Quek, SC, Hota, S, Tai, BC, Mujumdar, S, Tok, MY. Comparison of clinical outcomes and cost between surgical and transcatheter device closure of atrial septal defect in Singapore children. Ann Acad Med Singapore
2010; 39: 629–633.
Porstmann, W, Wierny, L, Warnke, H. Closure of ductus arteriosus persistens without thoractomy. Z Gesamte Inn Med
1968; 23: 142–143.
Rahman, MA, Djer, MM, Lefi, A. Transcatheter closure of secundum atrial septal defect with Amplatzer septal occluder: experience at Dr Soetomo Hospital Surabaya Indonesia. Cardiol Young
2010; 20 (Suppl 1): S392.
Morgan, G, Lee, KJ, Chaturvedi, R, Benson, L. A biodegradable device (BioSTAR(trademark)) for atrial septal defect closure in children. Catheter Cardiovasc Interv
2010; 76: 241–245.
Poommipanit, P, Levi, D, Shenoda, M, Tobis, J. Percutaneous retrieval of the locked HELEX septal occluder. Catheter Cardiovasc Interv
2011; 77: 892–900.
Thaman, R, Faganello, G, Gimeno, JR, et al. Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders. Heart
2011; 97: 394–399.
Tomar, M, Khatri, S, Radhakrishnan, S, Shrivastava, S. Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol
2011; 4: 22–27.
Otto, A, Aytemir, K, Ates, AH, et al. Transcatheter closure of secundum atrial septal defect using amplatzer and figulla septal occluder in adult patients: intermediate and long term follow-up results. Int J Cardiol
2011; 147 (Suppl 2): S70.
Sadiq, M, Kazmi, T, Rehman, AU, Latif, F, Hyder, N, Qureshi, SA. Outcome of device closure of ASD in intermediate and long term. Cardiol Young
2010; 20 (Suppl 2): S96.
Han, YM, Gu, X, Titus, JL, et al. New self-expanding patent foramen ovale occlusion device. Catheter Cardiovasc Interv
1999; 47: 370–380.
Dogan, U, Ozdemir, K, Narin, C, Akilli, H, Gulec, H, Gok, H. Embolization of atrial septal occluder device into the pulmonary artery. Int J Cardiol
2010; 140 (Suppl 1): S82.
Shirodkar, S, Patil, S, Pinto, R, Dalvi, B. Successful retrieval of migrated Amplatzer septal occluder. Ann Pediatr Cardiol
2010; 3: 83–86.
Amanullah, MM, Siddiqui, MT, Khan, MZ, Atiq, MA. Surgical rescue of embolized amplatzer devices. J Card Surg
2011; 26: 254–258.
Pieculewicz, M, Przewlocki, T, Wilkolek, P, et al. Arrhythmias after transcatheter closure of persistent foramen ovale are related to the type of the implanted device. Eur Heart J
2010; 31 (Suppl 1): S181.
Montgomery, J, Semder, C, Mendes, L, Fredi, J, Piana, R. Incidence of arrhythmia after percutaneous closure of PFO or ASD. Catheter Cardiovasc Interv
2011; 77 (Suppl 1): S30.
Taniguchi, M, Akagi, T, Ohtsuki, S, et al. Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Catheter Cardiovasc Interv
2009; 73: 682–686.
Khositseth, A, Cabalka, AK, Sweeney, JP, et al. Transcatheter amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc
2004; 79: 35–41.
Canpolat, U, Yorgun, H, Ates, AH, et al. Periprocedural thrombus formation during transcatheter closure of atrial septal defect with amplatzer (registered trademark) septal occluder. Int J Cardiol
2010; 140 (Suppl 1): S84–S85.
Barcin, C, Kursaklioglu, H, Baysan, O, Gungor, M, Kose, S. Percutaneous closure of atrial septal defect in adults: a single center experience. Int J Cardiol
2010; 140 (Suppl 1): S3–S4.
Reiss, N, Schuett, U, Maleszka, A, Kleikamp, G, Schenk, S, Gummert, J. Surgical removal of occluder devices: complications and pitfalls. Heart Surg Forum
2009; 12: E143–E146.